Sign in

Laurene Whyatt

Vice President and Equity Research Analyst at Barclays

Laurence Whyatt is a Vice President and Equity Research Analyst at Barclays, focusing on the European general sector with coverage notably including companies such as Diageo (GB:DGE) and Richemont (FR:RCO). He has covered 18 stocks and achieved a 46% success rate in his recommendations, delivering an average return of 2.6% per transaction and generating his most notable return of +61.3% on Diageo between March 2020 and March 2021. Laurence Whyatt began his analyst career prior to joining Barclays, though specific details about earlier roles are not publicly available; he has been publishing coverage at Barclays since at least 2017. His professional credentials include registration and activity tracked by market intelligence platforms, and he is recognized on TipRanks for his stock coverage performance.

Laurene Whyatt's questions to Anheuser-Busch InBev SA/NV (BUD) leadership

Question · Q3 2025

Laurene Whyatt asked for an update on consumer improvement in Brazil and Colombia, similar to the positive exit rate observed in Mexico. She also questioned if AB InBev still considers a net debt to EBITDA ratio below 2x to be value destructive and what actions would be taken if that metric were approached.

Answer

Michel Doukeris, Chief Executive Officer, explained that Mexico's improvement was due to normalized pricing and better weather. In Brazil, the industry remains heavily impacted by unseasonable weather, though AB InBev's share rebounded due to portfolio strength. Colombia, however, continues to show volume growth and improving share of alcohol beverages with more moderate inflationary pressures. Fernando Tennenbaum, Chief Financial Officer, reiterated that the optimal capital structure is around 2x net debt to EBITDA, but with less urgency once below this level, allowing for more flexibility. He emphasized that organic growth remains the number one priority.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts